Overview of metrological traceability of total PSA diagnostic kits inbrazilian clinical laboratories
Vigil Sanit Debate, Rio de Janeiro, 2024, v.12: e02203| Published on: 13/05/2024
DOI:
https://doi.org/10.22239/2317-269X.02203Keywords:
Metrological Traceability, Clinical Analyses-Laboratory Medicine, in vitro Diagnosis, Standardization of Laboratory Results, Harmonization of Laboratory Results, PSA TotalAbstract
Introduction: Specific Prostate Antigen (PSA) is crucial for monitoring prostate cancer, which is one of the leading causes of male mortality in Brazil and the USA. The reliability of PSA results provides an efficient diagnosis to direct to therapy, treatment response evaluation, and epidemiology. However, known discrepancies exist in the results obtained from different laboratories. Metrological traceability emerges as a key factor for the comparability and precision of these results and is a subject of little knowledge in the laboratory community. Objective: This study aimed to identify the metrological traceability of Total PSA kits registered in Brazil. Method: A search was conducted on the ANVISA product registration page, where the origin and instructions for use of the kits provided by in vitro diagnostic (IVD) manufacturers were analyzed. Results: The ANVISA data showed that 75.0% of IVD producers use the WHO 96/670 product, and 25.0% do not mention metrological traceability. Foreign products prevail (87.5%), with only two national kits registered, which do not provide information on traceability. Conclusions: the Brazilian market for Total PSA diagnostic kits (excluding rapid tests and free PSA) is predominantly dominated by foreign products that use the WHO 96/670 reference material. The lack of information on traceability in a significant number of IVD products highlights the need for regulatory and educational actions to promote awareness and compliance with metrological traceability principles of, thereby improving the quality and reliability of laboratory tests for public health protection.
Downloads
Author Biographies
-
Maria Cristina Ferreira Pessoa, Coordenação-Geral de Acreditação, Instituto Nacional de Metrologia, Qualidade e Tecnologia (Inmetro), Duque de Caxias, RJ, Brasil
-
José Mauro Granjeiro, Coordenação de Biologia, Instituto Nacional de Metrologia, Qualidade e Tecnologia (Inmetro), Duque de Caxias, RJ, Brasil
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Health Surveillance under Debate: Society, Science & Technology
This work is licensed under a Creative Commons Attribution 4.0 International License.
COPYRIGHT ALLOWANCE The author (s) hereinafter designated as the ASSIGNOR hereby assign and transfer, free of charge, the ownership of the copyrights related to this ARTICLE to the Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia (Health Surveillance under Debate: Society, Science & Technology) – Visa em Debate, represented by FUNDAÇÃO OSWALDO CRUZ, established at Av. Brasil, nº 4365, Manguinhos, Rio de Janeiro, RJ, Brazil, CEP 21045-900, under the conditions set out below: (a) The terms and conditions set forth in this Agreement shall apply to the following: 1. The ASSIGNOR declares that they s(he) is (are) the author (s) and owner (s) of the copyrighted property of the ARTICLE submitted. 2. The ASSIGNOR declares that the ARTICLE does not infringe the copyrights and / or other property rights of third parties, that the disclosure of images (if any) has been authorized and that they s(he) assume(s) full moral and / or property liability for its content, before third parties. 3. THE ASSIGNOR assigns and transfers all copyrights relating to the ARTICLE to the ASSIGNEE, especially the rights of editing, publication, translation into another language and reproduction by any process or technique. The ASSIGNEE becomes the exclusive owner of the rights related to the ARTICLE, and any reproduction, totally or partially, is prohibited in any other means of publicity, printed or electronic, without prior written authorization from the ASSIGNEE. 4. The assignment is free and, therefore, there will be no remuneration for the use of the ARTICLE by the ASSIGNEE.
